Simutaneous treatment of osteoporosis and hypertension

Details Simutaneous treatment of osteoporosis and hypertension Simutaneous treatment of osteoporosis and hypertension

1995-06-05

1998-06-16

Kulkosky, Peter F.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Carbonate

424722, 514878, A01N 5900, A61K 3300

Patent

active

057666407

ABSTRACT:
A method for simultaneously treating osteoporosis and hypertension in the same individual by the administration of pharmaceutically acceptable alkalinizing potassium salts, such as potassium bicarbonate, preferably in the form of a dietary supplement.

REFERENCES:
patent: 3105792 (1963-10-01), White
patent: 3337404 (1967-08-01), Polli et al.
patent: 4289750 (1981-09-01), Kopp et al.
patent: 4851221 (1989-07-01), Pak et al.
patent: 5171583 (1992-12-01), Morris, Jr. et al.
Abstract (Kidney Int. 31(1):353 1987 Zemann, Jr. et al).
Overlack et al., "The Influence of Oral Potassium Citrate Bicarbonate on Blood Pressure in Essential Hypertension during Unrestricted Salt Intake," Klin Woehenschr, 63:-352-360 (1985).

Affiliated with

Also associated with

Rating

Simutaneous treatment of osteoporosis and hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Simutaneous treatment of osteoporosis and hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simutaneous treatment of osteoporosis and hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1722246